Ledger.Open graph →
SEC Form D · filed June 8, 2018

ACTINOBAC BIOMED, INC

Offering
$6.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KENDALL PARK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

James Golubieski · Kendall Park, NJDirectorBenjamin Belinka, Jr · Kendall Park, NJExec · DirectorScott Kachlany · KENDALL PARK, NJDirectorPeter Alff · KENDALL PARK, NJDirectorScott Kachlany · Kendall Park, NJDirectorPeter Alff · Kendall Park, NJDirectorJames Golubieski · KENDALL PARK, NJDirectorBenjamin Belinka, Jr · Kendall Park, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗